Genetic profile of P. falciparum strains in villages around Soum irrigation Dam, Burkina Faso: insights from targeted sequencing of drug resistance markers in Pfkelch13, Pfubp1, Pfcoronin, Pfcrt, Pfmdr1, Pfdhps and Pfdhfr genes
The relatively high and expected frequency of P. falciparum and Pfdhfr and Pfdhps without significant variations between villages and transmission period suggests homogeneous circulation of these mutations across the study area and reflects continued pressure of SP.
Abstract
Hydro-agricultural settings may sustain high and prolonged malaria transmission and increase antimalarial drug use, potentially intensifying selection pressure on
P. falciparum
strains. Molecular surveillance in these settings is essential to detect changes in markers associated with resistance to artemisinin, Sulfadoxine-Pyrimethamine (SP), and Artemisinin-Based Combination Therapy (ACT) partner drugs. This study characterized the genetic profile and seasonal distribution of
P. falciparum
strains circulating in villages surrounding the Soum irrigation dam in Burkina Faso. A prospective monitoring approach was implemented through monthly repeated cross-sectional household surveys in five villages around the Soum dam in the Nanoro health district from March 2022 to February 2023. Dried blood spots from microscopy-positive samples were randomly selected by village and transmission season. Illumina technology was used to sequence molecular markers of partial resistance to artemisinin (
Pfkelch13
,
Pfcoronin
,
Pfubp1
), Sulfadoxine-Pyrimethamine (
Pfdhfr
,
Pfdhps
), and Artemisinin-Based Combination therapy (ACT) partner drugs (
Pfmdr1
,
Pfcrt
). Allele and haplotype prevalences were compared across villages, transmission seasons, and age groups using chi-square or Fisher’s exact tests, as appropriate. A total of 712
P. falciparum
-positive samples were selected for the sample size for molecular analysis. No validated or candidate mutations associated with artemisinin partial resistance were detected in
Pfkelch13 and Pfcoronin. Pfubp1
D1525E and E1528D mutations, suspected to be associated with delayed parasite clearance, were each detected at 18.5% and 19.1%, respectively. Mutant alleles of
Pfdhfr
, including 51
I
(73.7%), 59
R
(88.6%) and 108
N
(91.4%), were highly prevalent. In
Pfdhps
, the mutant 437
G
allele was highly detected (88.4%), whereas 431
V
, 540
E
and 581
G
occurred at low frequencies (< 2%). No significant variation was found between villages and transmission season for
Pfdhfr
and
Pfdhps
(
p
> 0.05). The wildtype 86 N allele of
Pfmdr1
was predominant (95.2%), while mutant allele 184 F (49.31%) was higher and differed significantly between villages (
p
= 0.029) with the highest frequency in Séguédin (57.4%) and the lowest in Soala (40.5%). The
Pfcrt
wildtype CVMNK haplotype (97.4%) remained dominant. This study found no validated
Pfkelch13
mutation and no candidate
Pfcoronin
mutation associated with artemisinin partial resistance. However, the emergence of D1525E and E1528D mutations of
Pfubp1
may suggest early signals adaptation of
P. falciparum
to artemisinin in the study area. The relatively high and expected frequency of
Pfdhfr
and
Pfdhps
without significant variations between villages and transmission period suggests homogeneous circulation of these mutations across the study area and reflects continued pressure of SP. The emerging
Pfdhps
431
V
and 540
E
and high frequency of
Pfmdr1
184
F
allele reinforced the need for regular surveillance to anticipate any resistance of SP and Lumefantrine.
Background Resistance to Artemisinin-based combination therapies (ACTs) threatens the backbone of Ghana’s success in Malaria control. In addition, malaria remains prevalent in the Central Region, raising concerns about the potential emergence of drug resistance. Mutations in the PfKelch13 gene associated with reduced s...
M. P. Dakorah, E. Aninagyei, Godwin Adzakpah et al.· Frontiers in Cellular and In...· 0 citations
BACKGROUND
Artemisinin derivatives are central to first-line treatment of both uncomplicated and severe Plasmodium falciparum malaria. Emerging artemisinin partial resistance in east Africa threatens to spread across the continent.
METHODS
In two cross-sectional studies conducted across the ten provinces of Zambia in...
M. Mwenda, Rafael Oliveira, B. Mambwe et al.· Lancet. Infectious Diseases...· 0 citations
Tanzania recently identified partial artemisinin resistance in the Kagera region bordering Rwanda and Uganda, where resistance is established. Monitoring neighboring regions is critical to guide containment strategies. We, therefore, conducted molecular surveillance of Plasmodium falciparum Kelch13 (pfk13) and Plasmodi...
K. Marwa, Rafael Oliveira, R. Mwaiswelo et al.· American Journal of Tropical...· 0 citations
Plasmodium falciparum, the protozoan responsible for malaria, has repeatedly developed resistance to antimalarial drugs, thereby thwarting efforts to malaria control and elimination. These resistances have contributed significantly to an increase in malaria-related mortality. Among the molecular markers of resistance,...
M. Koné, Félix Kouadio Yéboué, I. Abé et al.· GSC Advanced Research and Re...· 0 citations
ABSTRACT. Global efforts to control and eliminate malaria are threatened by antimalarial drug resistance. The WHO recommends molecular surveillance of resistance markers as a complementary approach to therapeutic efficacy studies. Here, the first regional analysis of antimalarial resistance markers across six southern...
Jaishree Raman, A. Aranda-Díaz, M. Mabona et al.· American Journal of Tropical...· 0 citations
Imported falciparum malaria remains an important challenge in China, particularly with the emergence of antimalarial resistance in Africa. This study characterized resistance-associated mutations in pfk13, pfcrt and pfmdr1 by nested PCR and Sanger sequencing of 291 Plasmodium falciparum (P. falciparum) isolates importe...
Li-Jun Chen, Qiang Mao, De Wu et al.· Pathogens· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.